华特达因(000915.SZ)2月3日在投资者互动平台透露，其儿童褪黑素颗粒产品曼乐静已正式在京东、阿里等线上平台开启销售，并计划后续逐步拓展至国内各地线下医院，实现线上线下全渠道覆盖。公司当前生产经营及销售状况均保持正常状态，针对股价波动问题，公司表示这主要受宏观环境等多重因素影响。未来，华特达因将继续聚焦主业，不断提升自身核心竞争力，致力于以出色的经营业绩回馈广大投资者。
Source Link华特达因(000915.SZ)2月3日在投资者互动平台透露，其儿童褪黑素颗粒产品曼乐静已正式在京东、阿里等线上平台开启销售，并计划后续逐步拓展至国内各地线下医院，实现线上线下全渠道覆盖。公司当前生产经营及销售状况均保持正常状态，针对股价波动问题，公司表示这主要受宏观环境等多重因素影响。未来，华特达因将继续聚焦主业，不断提升自身核心竞争力，致力于以出色的经营业绩回馈广大投资者。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.